Literature DB >> 303961

A programme of multiple-antigen childhood immunization in Yaoundé, Cameroon: first-year evaluation, 1975-1976.

B Guyer, S Atangana.   

Abstract

The Yaoundé multiple-antigen childhood immunization programme began in November 1975, making it one of the first expanded programmes on immunization operational in Africa. During the first 9 months, more than 22 000 children were immunized against poliomyelitis, measles, tuberculosis, smallpox, whooping cough, tetanus, and diphtheria. Evaluation of the programme showed the following rates of immunization coverage in the target population; 30% for DPT (one dose or more), 27% for poliomyelitis (one dose or more), 27% for BCG, 33% for measles, and 20% for smallpox. Eighty per cent of children received the correct vaccines for their age and vaccination status. Seroconversion to measles vaccine was 89% in those over 12 months of age but only 50% in those between 6 and 11 months of age. The major factor in low immunization coverage was felt to be inadequate publicity. The cost of the programme was estimated to be US $10 920. The cost of immunizing a child completely was estimated at US $1.90. Some logistic problems encountered during this initial year of operation are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303961      PMCID: PMC2366693     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Persistence of malaria antibody in Tobago, West Indies, following eradication, as measured by the indirect hemagglutination test.

Authors:  H M Mathews; G U Fisher; I G Kagan
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

2.  Standardized viral hemagglutination and hemagglutination-inhibition tests. I. Standardization of erythrocyte suspensions.

Authors:  J C Hierholzer; M T Suggs
Journal:  Appl Microbiol       Date:  1969-11

3.  Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation.

Authors:  J C Hierholzer; M T Suggs; E C Hall
Journal:  Appl Microbiol       Date:  1969-11

4.  Evaluation of a measles-smallpox vaccination campaign by a sero-epidemiologic method.

Authors:  J G Breman; E Coffi; R Bomba-Ire; S O Foster; K L Herrmann
Journal:  Am J Epidemiol       Date:  1975-12       Impact factor: 4.897

5.  Assessment of vaccination coverage, vaccination scar rates, and smallpox scarring in five areas of West Africa.

Authors:  R H Henderson; H Davis; D L Eddins; W H Foege
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

  5 in total
  7 in total

1.  Injections and paralytic poliomyelitis in tropical Africa.

Authors:  B Guyer; A A Bisong; J Gould; M Brigaud; M Aymard
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

2.  Comparison of Reported and Survey-Based Coverage in Onchocerciasis Programs over a Period of 8 Years in Cameroon and Uganda.

Authors:  Moses N Katabarwa; Emily Griswold; Peace Habomugisha; Albert Eyamba; Edson Byamukama; Philippe Nwane; Annet Khainza; Lauri Bernard; Paul Weiss; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

Review 3.  Systematic review of the incremental costs of interventions that increase immunization coverage.

Authors:  Sachiko Ozawa; Tatenda T Yemeke; Kimberly M Thompson
Journal:  Vaccine       Date:  2018-05-10       Impact factor: 3.641

4.  Heterogeneity in the validity of administrative-based estimates of immunization coverage across health districts in Burkina Faso: implications for measurement, monitoring and planning.

Authors:  Slim Haddad; Abel Bicaba; Marta Feletto; Pierre Fournier; Maria Victoria Zunzunegui
Journal:  Health Policy Plan       Date:  2010-02-25       Impact factor: 3.344

5.  Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens.

Authors:  Moses Ndiritu; Karen D Cowgill; Amina Ismail; Salome Chiphatsi; Tatu Kamau; Gregory Fegan; Daniel R Feikin; Charles R J C Newton; J Anthony G Scott
Journal:  BMC Public Health       Date:  2006-05-17       Impact factor: 3.295

6.  Determinants of immunisation coverage of children aged 12-59 months in Indonesia: a cross-sectional study.

Authors:  Putri Herliana; Abdel Douiri
Journal:  BMJ Open       Date:  2017-12-22       Impact factor: 2.692

7.  Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.

Authors:  Sara Carazo; Marie-Noëlle Billard; Amélie Boutin; Gaston De Serres
Journal:  BMC Infect Dis       Date:  2020-03-29       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.